G

Global Longlife Hospital & Research Ltd

GLHRL
Market snapshot · 2026-08-11 01:50 UTC

12.39

₹-0.65 (-4.98%)

MARKET CAP

₹13.01 Cr

STOCK P/E

52W HIGH

₹26.73

52W LOW

₹9.00

BOOK VALUE

₹22.62

EPS

₹-1.64

ROE

-6.80%

SECTOR

Healthcare

DEBT/EQUITY

VOLUME

5.36L

P/B RATIO

0.55x

PEG RATIO

Sector

Healthcare

Themes

Medical Care Facilities
₹25.51₹21.62₹17.73₹13.83₹9.94VolumeAug '25Sep '25Nov '25Jan '26Mar '26Apr '26Jun '26Aug '26

AI Summary

✦ Clartha

Valuation Metrics

Forward Valuation Outlook

Forward outlook is unavailable because live next-12-month estimate data is not available for this ticker right now.

EV/EBITDA
Undervalued

5Y Average

Current

7.84

Overvalued

9.02

Undervalued

6.67

P/S
Undervalued

5Y Average

Current

2501.83

Overvalued

2877.10

Undervalued

2126.55

P/B
Strongly Undervalued

5Y Average

0.79

Current

0.55

Overvalued

0.91

Undervalued

0.67

Peers & Comparison

No peer data available for this company.
WHY THESE PEERS

No sector data available for this company.

Financials

Real statement data for revenue, earnings quality, conversion, and balance-sheet coverage. Monetary values are shown in Rs crore.

Latest revenue

₹0.00 CrMar 2026

Latest net profit

₹-0.40 CrMar 2026

Latest EPS

₹-0.38Mar 2026

Free cash flow

₹-4.51 CrMar 2026

Performance

Bars show revenue and net profit. The line shows net margin.

Rs crore + margin %
Q4 '25Q1 '26Q2 '26Q3 '26Q4 '26-1.40 Cr-1.05 Cr-0.70 Cr-0.35 Cr0.00 Cr
  • Revenue
  • Net income
  • Net margin %

Earnings

Revenue is shown in crores. EPS is rupees per share.

Rs crore + Rs/share
Q4 '25Q1 '26Q2 '26Q3 '26Q4 '260.00 Cr1.00 Cr2.00 Cr3.00 Cr4.00 Cr₹-2₹-1₹-1₹-1₹-0
  • Revenue
  • EPS

Revenue to profit conversion

Bridge from operating numbers to profit for the latest reported period.

Rs crore
RevenueExpensesDepreciationOperatingprofitOther incomeInterestProfitbefore taxTax & otherNet Profit-0.40 Cr-0.30 Cr-0.20 Cr-0.10 Cr0.00 Cr

Latest reported period: Mar 2026

Debt level and coverage

Debt, cash and free cash flow compared on the same crore scale.

Rs crore
Annual view
Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026-80 Cr-40 Cr0.00 Cr40 Cr80 Cr
  • Debt
  • Free cash flow
  • Cash & equivalents

Results

MetricSep 2021Mar 2022Sep 2022Mar 2023Sep 2023Mar 2024Sep 2024Mar 2025Sep 2025Mar 2026
Sales +19.9412.8711.8011.7012.331.180.580.000.000.00
Expenses +13.1811.6110.039.449.624.204.390.350.600.40
Operating Profit6.761.261.772.262.71-3.02-3.81-0.35-0.60-0.40
OPM %33.90%9.79%15.00%19.32%21.98%-255.93%-656.90%
Other Income +0.070.160.070.170.020.045.69-0.670.010.00
Interest0.091.310.200.200.410.360.280.000.000.00
Depreciation0.580.570.580.590.610.640.480.000.000.00
Profit before tax6.16-0.461.061.641.71-3.981.12-1.02-0.59-0.40
Tax %0.00%-78.26%29.25%35.37%39.77%-19.10%-11.61%2.94%123.73%0.00%
Net Profit +6.17-0.100.761.071.03-3.221.24-1.04-1.32-0.40
EPS in Rs8.81-0.140.721.020.98-3.071.18-0.99-1.26-0.38
Raw PDF

All values in ₹ Crores unless otherwise stated. Source: Screener Master (Standalone).

Loading shareholding pattern...

Events Timeline

Annual Report FY26

FY2026PDFCompany Reports Open

Disclosures under Reg. 29(2) of SEBI (SAST) Regulations, 2011

Aug 10, 2026PDFCompany Reports Open

Disclosures under Reg. 29(2) of SEBI (SAST) Regulations, 2011

Aug 03, 2026PDFCompany Reports Open

Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018

Jul 24, 2026PDFCompany Reports Open

Announcement under Regulation 30 (LODR)-Change in Management

Jun 26, 2026PDFCompany Reports Open